[Research Report] The infection control supplies market size is expected to reach US$ 4,382.41 million by 2031 from US$ 3,323.00 million in 2022. The market is estimated to grow at a CAGR of 3.4% from 2022 to 2031.

Market Insights and Analyst View:

The infection control supply market encompasses a wide range of products and equipment designed to prevent and control the spread of infection in various settings, including healthcare facilities, laboratories, and public spaces. The prevalence of hospital-acquired infections remains a significant concern in healthcare settings. As a result, there is a growing demand for infection control supplies such as disinfectants, hand sanitizers, and personal protective equipment to reduce the risk of infections among patients and healthcare workers. Expanding healthcare infrastructure and increased healthcare spending globally have increased the demand for infection control supplies to ensure patient safety and hygiene. Growing healthcare infrastructure and increasing focus on infection prevention in emerging markets create new opportunities for infection control supply manufacturers. Rise in the number of surgical procedures that require high-intensity infection prevention & control, a surge in the number of government awareness programs to ensure a high degree of infection prevention, a rise in the geriatric population, and a surge in cases of chronic diseases such as obesity, diabetes, cancer, and respiratory disorders are the factors that are expected to drive the growth of the market.

Growth Drivers and Challenges:

Healthcare facilities in various countries such as India, Bangladesh and Japan pose a risk of infection to patients. Every year, in hospitals, infections causes unnecessary suffering and the death of millions of patients. Risks for emerging infectious diseases in the Asia Pacific are complex and believed to involve socioeconomic, environmental, and technological processes promoting the dynamics of microbial transmission. According to the National Institutes of Health, in Asia-Pacific the risk of hospital-acquired infections (HAIs) is 2–20 times higher as compared in developed countries, with ~25% of hospitalized patients reporting infections. According to the Centers for Disease Control and Prevention (CDC) in US, ~1 in 31 patients in hospitals suffers from hospital-acquired infection. Furthermore, according to the data provided by PatientCareLink, in American Hospitals alone, hospital-acquired infections account for an 1.7 million infection cases and 99,000 associated diseases yearly. 

Healthcare facilities in low and middle-income countries have extremely high hospital-acquired infections rates, due to the additional challenges in achieving effective infection control, absence of cleanliness in hospitals, and lack of awareness regarding infection control. Seriously ill patients are more susceptible to infections in industrialized and developing countries. Increase in HAI cases has drove the need for preoperative infection prevention devices, thereby driving the infection control supplies market growth.

Strategic Insights

Report Segmentation and Scope:

The global infection control supplies market is segmented based on type and end user. Based on the type, the market is segmented into sterilization equipment, cleaning and disinfection equipment, disposable safety products, and others. By disposable safety products, the infection control supplies market is further segmented into gloves & goggles, covers & closures, face masks, surgical drapes and gowns, and others. The sterilization equipment segment is anticipated to register the highest CAGR during 2022–2031. Based on end users, the infection control supplies market is segmented into healthcare facilities, medical device & pharmaceutical companies, laboratories, and others. The healthcare facilities segment held the largest market share in 2022, and the same segment is expected to register the highest CAGR during the forecast period (2022–2031). The infection control supplies market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, the U.K., Russia, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Segmental Analysis:

Based on type, the infection control supplies market is segmented into sterilization equipment, cleaning and disinfection equipment, disposable safety products, and others. The sterilization equipment segment is further segmented into heat sterilization equipment, radiation sterilization equipment, filtration sterilization equipment, consumables & accessories. The infection control supplies market, by disposable safety products, is further segmented into gloves & goggles, covers & closures, face masks, surgical drapes and gowns, and others. The sterilization equipment segment is anticipated to register the highest CAGR during 2022–2031. Sterilization equipment is essential in various industries, particularly healthcare and laboratory settings, to ensure that instruments, equipment, and materials are free from microorganisms such as bacteria, viruses, and fungi. The growth of sterilization equipment is driven by several factors, reflecting its crucial role in various industries, including healthcare, pharmaceuticals, laboratory, and food production. The demand for healthcare services continues to rise globally, leading to a higher need for sterilization equipment to ensure the safety of medical instruments, equipment, and devices. Awareness of the importance of infection control and prevention of healthcare-associated infections is increasing. This drives the adoption of advanced sterilization methods and equipment in healthcare settings. The Pharmaceutical industry relies on sterilization to maintain product quality and safety. As this industry expands, so does the demand for sterilization equipment to ensure the stability of pharmaceutical products and production environments. Technological advancement in sterilization methods and equipment includes developing faster, more efficient, and environmentally friendly systems, encouraging adoption, and replacing older equipment. For instance, Nanosonics launched Nanosonics AuditPro, a new digital product platform offering traceability, reporting, and workflow compliance, at the annual Association for Professionals in Infection Control and Epidemiology (APIC) virtual conference. Introducing Nanosonics AuditPro will offer infection preventionists and Quality managers an opportunity to improve and standardize infection control compliance across a broad range of medical instruments to support the management of healthcare-associated infection (HAI) risk. Based on end users, the infection control supplies market is segmented into healthcare facilities, medical device & pharmaceutical companies, laboratories, and others. The healthcare facilities segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period (2022–2031).    

The infection control supplies market, by type, is segmented into sterilization equipment, cleaning and disinfection equipment, disposable safety products, and others. The sterilization equipment segment held the largest market share in 2022, which is anticipated to register a higher CAGR during 2022–2031.

Regional Analysis:

Based on geography, the infection control supplies market is categorized into five key regions: North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. The U.S. held the largest share of the North America infection control supplies market 2022. It is estimated to hold North America's largest share of the infection control supplies market during the forecast period, owing to the growing prevalence of hospital-acquired infections, high spending on research and development, product approvals by the U.S. Food and Drug Administration (FDA), and technological advances. Several factors have driven the U.S.'s rising demand for infection control supplies. Hospitals and healthcare facilities require constant suppliers of infection control supplies to maintain a clean and safe for patients and healthcare workers. This includes disinfectant, sanitizer, disposable gowns, and respiratory protection equipment. HAIs are an increasingly significant problem in hospitals and healthcare facilities, putting additional pressure on the healthcare system, facility staff, and patients. Infection prevention equipment reduces the transmission of infectious diseases when other measures, such as engineering controls and labor practices, cannot eliminate exposure. Federal, state, and local governments implemented various initiatives to combat the spread of COVID-19. During the COVID-19, the number of hospital admissions was on the rise. Regarding the total annual cost spent on these infections by healthcare facilities, SSIs are the largest contributor in the U.S. The most common types of HAIs cost around US$ 9.8 billion annually in the U.S. These efforts often included distributing infection control supplies to needy communities.

Furthermore, according to the Australasian College for Infection Prevention and Control, approximately 165,000 hospital-acquired infections (HAIs) were diagnosed in private and public hospitals in Australia in 2021, considered one of the most common complications in hospitalized patients. HAI also contributes to a significant increase in the morbidity and mortality rate and an exponentially increasing risk of readmission within 12 months. According to the same study, HAIs also often result in prolonged hospital stays, averaging 18.1 days longer than patients without these hospital-acquired complications. The national average cost per approved overnight stay is USD 2074. The consequence of the more extended hospital stays with HAI can, therefore, is associated with additional charges of 37,539 USD. HAI rates can be reduced significantly by implementing infection control procedures and equipment such as hygiene washers and disposable slings. Thus, the market is expected to grow during the forecasted period due to the increasing HAIs.

Competitive Landscape and Key Companies:

Infection control supplies market developments have been characterized as organic and inorganic growth strategies. Various companies focus on organic growth strategies such as product launches, expansion, enhancement, and relocation. Inorganic growth strategies in the market are mergers and acquisitions, partnerships, and collaborations. These activities have paved the way for the expansion of businesses, and customer base of infection control supplies market players.

• In August 2021, Ecolab Inc. opened the Ecolab Healthcare Advanced Design Center in Eagan, Minn. The state-of-the-art, 22,000-square-foot innovation center will enable Ecolab Healthcare to partner with medical device industry customers on infection prevention solutions for their cutting-edge surgical equipment and develop new solutions for hospitals and surgery centers. Custom-designed sterile barriers and equipment drapes help hospitals and surgery centers boost infection prevention measures, improve patient outcomes, and manage operational costs and efficiencies. 
• In January 2022, UVD Robots Collaborated with Ecolab to Fight Hospital-Acquired Infections Globally to distribute its UV-C systems worldwide.
• In August 2021, Advanced Sterilization Products Launched the Fastest Biological Indicator for Hydrogen Peroxide Sterilization in Asia Pacific.
• In June 2023, STERIS plc announced that the Company signed an agreement to purchase the surgical instrumentation, laparoscopic instrumentation, and sterilization container assets from Becton, Dickinson, and Company for $540 million.
• In January 2021, STERIS plc signed a definitive agreement to acquire Cantel through a U.S. subsidiary. Under the terms of the agreement, STERIS acquired Cantel in a cash and stock transaction valued at $84.66 per Cantel common share, based on STERIS’s closing share price of $200.46.
• In May 2022, Getinge launched superfast indicators to ensure patient safety further. Getinge Assured Superfast 20 Biological Indicator speeds up the ability of the Central Sterile Supply Department (CSSD) to release loads safely, ensuring that the sterile instruments can be in the right place at the right time.

Company Profiles

• Advanced Sterilization Products
• Systec GMBH
• Ecolab
• Belimed
• STERUS Corporation
• Cardinal Health
• Getinge AB
• Matachana Group
• Contec Healthcare
• Pal International

Download Free Sample

   Inquire for Discount   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
• Request discounts available for Start-Ups & Universities

REGIONAL FRAMEWORK MARKET PLAYERS

Download Free Sample

   Inquire for Discount   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
• Request discounts available for Start-Ups & Universities